Status:
UNKNOWN
Airway Nerve Block Versus Nebulization by Lignocaine During Diagnostic Flexible Bronchoscopy Under Moderate Sedation.
Lead Sponsor:
Ain Shams University
Conditions:
Anesthesia
Eligibility:
All Genders
21-70 years
Phase:
NA
Brief Summary
To compare the effectiveness of nebulization versus airway nerve block technique to achieve upper airway anesthesia for diagnostic fiberoptic bronchoscopy under moderate sedation.
Detailed Description
Randomization was done using computer generated tables of random numbers: Group A (nebulized lignocaine group) as a control group (n = 60) received 5 ml of 10% lignocaine by air driven jet nebulizer ...
Eligibility Criteria
Inclusion
- Patients planned for diagnostic fiberoptic procedures such as broncho-alveolar lavage, endobronchial or transbronchial biopsies, or brush cytology.
Exclusion
- Patients less than 21yrs old and patients more than 70 yrs old.
- Severe respiratory failure (pH \< 7.35, partial arterial oxygen pressure \<55 mmHg despite supplemental oxygen).
- Upper airway surgery or radiation, allergy to lidocaine, Propofol or midazolam, or bleeding disorder.
- Hemodynamic instable patient or patient decompensated heart failure.
- Epileptic patients, severe neurological or psychiatric disorder.
- Patients requiring cryo-biopsy or endobronchial ultrasound because these procedures are performed under deep sedation including fiberoptic intubation.
Key Trial Info
Start Date :
March 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 21 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04806438
Start Date
March 21 2021
End Date
July 21 2021
Last Update
March 19 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.